VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

Part of paid clinical trials in New York, New York.

Sponsor
Regeneron Pharmaceuticals
Study ID
NCT00036946
Phase
PHASE1
Status
Completed

Conditions

  • Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific

Eligibility Criteria

Sex
ALL
Age
25 Years - 120 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: VEGF Trap may stop the growth of solid tumors or non-Hodgkin's lymphoma by stopping blood flow to the cancer. PURPOSE: Phase I trial to study the effectiveness of VEGF Trap in patients who have relapsed or refractory solid tumors or non-Hodgkin's lymphoma.

Key Dates

First listed
Jan 27, 2003
Start date
Nov 30, 2001
Status verified
Jun 2016
Primary completion
Mar 31, 2002

Study Design

Primary purpose
TREATMENT

Locations (1)

FacilityCityStateZIPSite coordinators
Memorial Sloan-Kettering Cancer CenterNew YorkNew York10021-

Find similar trials in New York, NY

By research site
Memorial Sloan-Kettering Cancer Center· New York, NY

Related Studies